These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21089607)

  • 1. [Structure and function analysis of gamma-secretase complex toward development of therapeutics for Alzheimer's disease].
    Tomita T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1684-9. PubMed ID: 21089607
    [No Abstract]   [Full Text] [Related]  

  • 2. γ-Secretase component presenilin is important for microglia β-amyloid clearance.
    Farfara D; Trudler D; Segev-Amzaleg N; Galron R; Stein R; Frenkel D
    Ann Neurol; 2011 Jan; 69(1):170-80. PubMed ID: 21280087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-secretase and the intramembrane proteolysis of Notch.
    Jorissen E; De Strooper B
    Curr Top Dev Biol; 2010; 92():201-30. PubMed ID: 20816396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease.
    De Strooper B; Iwatsubo T; Wolfe MS
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a006304. PubMed ID: 22315713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biology and pathobiology of the intramembrane proteolysis by gamma-secretase].
    Tomita T
    Tanpakushitsu Kakusan Koso; 2009 Oct; 54(13):1747-53. PubMed ID: 19827607
    [No Abstract]   [Full Text] [Related]  

  • 6. Presenilin: running with scissors in the membrane.
    Selkoe DJ; Wolfe MS
    Cell; 2007 Oct; 131(2):215-21. PubMed ID: 17956719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.
    Wolfe MS; De Los Angeles J; Miller DD; Xia W; Selkoe DJ
    Biochemistry; 1999 Aug; 38(35):11223-30. PubMed ID: 10471271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.
    Zettl H; Ness J; Hähnke V; Beher D; Jumpertz T; Saric A; Baumann K; Pietrzik CU; Bulic B; Schneider G; Weggen S
    ACS Chem Biol; 2012 Sep; 7(9):1488-95. PubMed ID: 22725102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel research horizons for presenilins and γ-secretases in cell biology and disease.
    De Strooper B; Annaert W
    Annu Rev Cell Dev Biol; 2010; 26():235-60. PubMed ID: 20604710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: from pathology to therapeutic approaches.
    Jakob-Roetne R; Jacobsen H
    Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure and function of Alzheimer's gamma secretase enzyme complex.
    Krishnaswamy S; Verdile G; Groth D; Kanyenda L; Martins RN
    Crit Rev Clin Lab Sci; 2009; 46(5-6):282-301. PubMed ID: 19958215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of gamma-secretase activity in Alzheimer's disease.
    Zhou S; Zhou H; Walian PJ; Jap BK
    Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc.
    Hoke DE; Tan JL; Ilaya NT; Culvenor JG; Smith SJ; White AR; Masters CL; Evin GM
    FEBS J; 2005 Nov; 272(21):5544-57. PubMed ID: 16262694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
    Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
    Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-secretase: a complex target for Alzheimer's disease.
    Lundkvist J; Näslund J
    Curr Opin Pharmacol; 2007 Feb; 7(1):112-8. PubMed ID: 17169612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin diversifies its portfolio.
    Parks AL; Curtis D
    Trends Genet; 2007 Mar; 23(3):140-50. PubMed ID: 17280736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.